On Thursday, Following Stocks were among the “Top 100 Gainers” In U.S. Stock Exchange: Frontline (NYSE:FRO), W&T Offshore, (NYSE:WTI), Walter Energy, (NYSE:WLT), Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Frontline Ltd (NYSE:FRO) inclined .46%, and closed at $2.39. The company has the market capitalization of $275.35 million. The beta value of the stock is 2.40. On the other hand the stock’s volatility for the week is 5.25%, and for the month is 5.11%. The stock’s price to sale ratio is $0.49. Analyst’s mean recommendation regarding this stock is 3.40. (Where 1=Buy, 5=Sale).
Frontline Ltd (FRO) along with its subsidiaries owns and works oil tankers and oil/bulk/ore carriers. The corporation provides seaborne transportation of crude oil and oil products.
W&T Offshore, Inc. (NYSE:WTI)’s shares picked up 3.43%, and closed at $5.43. The stock volatility for the week is 5.51%, while for the month remained 6.49%. The company holds consensus target price of $7.06.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.15 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -122.10% and Annual EPS growth for the past 5 years is considered as 43.10%.
The mean recommendation of analysts for this stock is 2.70. (Where 1=Buy, 5=Sale).
W&T Offshore, Inc. (WTI) an independent oil and natural gas producer, along with its subsidiaries, engages in the acquisition, exploration, and development of oil and natural gas properties primarily in the Gulf of Mexico and onshore in the Permian Basin of West Texas. It holds working interests in approximately 63 offshore fields in federal and state waters.
Walter Energy, Inc. (NYSE:WLT) a leading, publicly traded “pure-play” producer of metallurgical coal for the global steel industry, divulged that the Company has been notified by the New York Stock Exchange that its common stock does not presently satisfy one of the NYSE’s continued listing standards. The NYSE requires that the average closing price per share of a listed company’s common stock be at least $1.00 over a consecutive 30 trading-day period. As of March 3, 2015, the average closing price per share of the Company’s common stock over the preceding 30 trading-day period was $0.99. Under the NYSE’s rules, the Company has six months to regain compliance with the NYSE’s continued listing standards. The Company’s common stock will continue to be listed and traded on the NYSE during this period, subject to the Company’s compliance with other continued listing standards. As required by the NYSE’s rules, the Company plans to notify the NYSE within 10 business days of the receipt of the notice of non-compliance of its intent to cure the deficiency.
Walter Energy, Inc. (NYSE:WLT) enhanced 3.39%, and closed at $0.61. The company holds the market capitalization of $43.99 million. For the last twelve months, the stock was able to keep return on equity at -95.90%, while return on assets at -8.50%, in response to its return on investment at -5.10%. Its 20-day moving average decreased -12.67%, below 50-day moving average of -32.07%, below 200-day moving average of -79.77% from the latest market price of $0.61. The mean recommendation of analysts for this stock is 3.30. (Where 1=Buy, 5=Sale).
Walter Energy, Inc. (WLT) makes and exports metallurgical coal for the steel industry. It works through two segments, U.S. Operations, and Canadian and U.K. Operations. The company also extracts, processes, markets, and/or possesses mineral reserves of thermal coal and anthracite coal, as well as produces metallurgical coke and coal bed methane gas.
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) disclosed the closing of its underwritten public offering of 4,945,000 shares of common stock at an offering price of $35.00 per share. The shares of common stock issued and sold in the offering at the closing include 645,000 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares at the offering price. The gross proceeds to Tetraphase from this offering were $173.1 million, before deducting underwriting discounts and commissions and offering expenses payable by Tetraphase.
Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) rose 3.39%, and closed at $35.38.its volatility for the week is 8.77%, while for the month it is 6.68%. The company has the market capitalization of $1.27 billion. The company holds the book value per share of 3.66, whereas cash per share is 3.37. Price to book ratio remained 9.67, while price to sale ratio is 139.65. Analysts mean recommendation for the stock is said to be 1.50 (where 1=Buy, 5=sale).
Tetraphase Pharmaceuticals Inc (TTPH) clinical-stage Biopharmaceutical Company, develops various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections. Its lead product candidate includes eravacycline, an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
